Page 9 - Agilent Microarray News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Agilent microarray. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Agilent Microarray Today - Breaking & Trending Today

Agilent, Akoya Partner To Drive Multiplex Tissue Assay Development For Biopharma Applications

SANTA CLARA (dpa-AFX) - Agilent Technologies Inc. (A) said that it has partnered with Akoya Biosciences Inc. (AKYA) to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis ....

Dako Omnis , Agilent Dako Omnis , Akoya Biosciences , Agilent Technologies Inc , Akoya Biosciences Inc , Value Added Reseller ,

Research and Markets: Global Capillary Electrophoresis Strategic Business Report 2022: Featuring Agilent Technologies, Bio-Rad Laboratories, Danaher and Helena Laboratories Among Others

The "Capillary Electrophoresis: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Capillary Electrophoresis estimated at US$882.1 ....

United States , South Korea , Laura Wood , Agilent Technologies Inc , Office Hours Call , Perkinelmer Inc , Helena Laboratories Corp , Pharma Biotech Companies , E St Office Hours Call , Bio Rad Laboratories Inc , Danaher Corp , Thermo Fisher Scientific Inc , Research Platform , Promega Corp , Global Strategic Business , Capillary Electrophoresis , While China , End Use Segment , Rad Laboratories , Fisher Scientific , Topics Covered , Market Insights , Market Trajectories , Looming Global Recession , Market Presence , Players Worldwide ,

"The penetration of genetic testing still remains abysmally low in a country like India"

“The penetration of genetic testing still remains abysmally low in a country like India” ....

Manbeena Chawla , Agilent Microarray , Agilent Technologies , Biospectrum India , Country General Manager , Agilent Magnis , Agilent India ,

Liquid Biopsy CDx Test for Advanced Non-small Cell Lung Cancer Receives FDA Approval

The US Food and Drug Administration (FDA) has approved Agilent Resolution ctDx FIRST as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients with KRAS G12C mutations who may benefit from treatment with KRAZATITM (adagrasib). Click to read more. ....

Alan Sandler , Kenna Anderes , Sam Raha , Genomics Group , Drug Administration , Agilent Resolution , Vice President , Translational Medicine , Chief Medical ,

Agilent Technologies : Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer

Agilent Technologies Inc. announced today that the U.S. Food and Drug Administration has approved Agilent Resolution ctDx FIRST as a companion diagnostic to identify advanced. | December 12, 2022 ....

United States , Alan Sandler , Kenna Anderes , Sam Raha , Dacosta Byfield , Agilent Technologies Inc , Genomics Group , Cancer Center , Drug Administration , American Cancer Society , Agilent Technologies , Agilent Resolution , Vice President , Translational Medicine , Chief Medical , Key Statistics , American Cancer , About Lung Cancer Web , Retrospective Analysis , Lung Cancer , Clinicoecon Outcomes , Somatic Mutations , Patient Reported Preferences , Liquid Biopsies , Blood Biomarkers , Comprehensive Cancer ,